Listed

aTYR PHARMA INC

ATYRNasdaqCIK 1339970HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q4 FY2025
Operating income−$10.9m, Q2 FY2026
Net income−$10.3m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.4Revenue, Q3 FY2023, three months to 2023-09-30$353.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0000950170-24-123305.Report this figure0.0Revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001339970-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure0.2Revenue, Q1 FY2024, three months to 2024-03-31$235.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-07, accession 0000950170-25-065640.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001339970-25-000009.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269587.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001339970-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-07, accession 0000950170-25-065640.Report this figure0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001339970-25-000009.Report this figure0.2Revenue, Q3 FY2025, three months to 2025-09-30$190.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269587.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001339970-26-000008. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Research and development$m10.3Research and development, Q3 FY2023, three months to 2023-09-30$10.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123305.Report this figure12.8Research and development, Q4 FY2023, three months to 2023-12-31$12.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001339970-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure13.4Research and development, Q1 FY2024, three months to 2024-03-31$13.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-07, accession 0000950170-25-065640.Report this figure14.0Research and development, Q2 FY2024, three months to 2024-06-30$14.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001339970-25-000009.Report this figure14.8Research and development, Q3 FY2024, three months to 2024-09-30$14.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269587.Report this figure12.2Research and development, Q4 FY2024, three months to 2024-12-31$12.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001339970-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure11.8Research and development, Q1 FY2025, three months to 2025-03-31$11.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure15.4Research and development, Q2 FY2025, three months to 2025-06-30$15.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure22.1Research and development, Q3 FY2025, three months to 2025-09-30$22.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269587.Report this figure10.9Research and development, Q4 FY2025, three months to 2025-12-31$10.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001339970-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure7.3Research and development, Q1 FY2026, three months to 2026-03-31$7.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure6.7Research and development, Q2 FY2026, three months to 2026-06-30$6.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure
Operating income$m(12.6)Operating income, Q3 FY2023, three months to 2023-09-30−$12.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123305.Report this figure(16.0)Operating income, Q4 FY2023, three months to 2023-12-31−$16.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001339970-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(16.6)Operating income, Q1 FY2024, three months to 2024-03-31−$16.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-07, accession 0000950170-25-065640.Report this figure(17.3)Operating income, Q2 FY2024, three months to 2024-06-30−$17.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001339970-25-000009.Report this figure(18.1)Operating income, Q3 FY2024, three months to 2024-09-30−$18.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269587.Report this figure(15.8)Operating income, Q4 FY2024, three months to 2024-12-31−$15.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001339970-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(15.8)Operating income, Q1 FY2025, three months to 2025-03-31−$15.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure(20.3)Operating income, Q2 FY2025, three months to 2025-06-30−$20.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure(26.7)Operating income, Q3 FY2025, three months to 2025-09-30−$26.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269587.Report this figure(14.8)Operating income, Q4 FY2025, three months to 2025-12-31−$14.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001339970-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(11.4)Operating income, Q1 FY2026, three months to 2026-03-31−$11.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure(10.9)Operating income, Q2 FY2026, three months to 2026-06-30−$10.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure
Net income$m(11.3)Net income, Q3 FY2023, three months to 2023-09-30−$11.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123305.Report this figure(14.8)Net income, Q4 FY2023, three months to 2023-12-31−$14.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001339970-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(15.5)Net income, Q1 FY2024, three months to 2024-03-31−$15.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-07, accession 0000950170-25-065640.Report this figure(16.3)Net income, Q2 FY2024, three months to 2024-06-30−$16.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-07, accession 0001339970-25-000009.Report this figure(17.3)Net income, Q3 FY2024, three months to 2024-09-30−$17.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269587.Report this figure(15.0)Net income, Q4 FY2024, three months to 2024-12-31−$15.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001339970-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(14.9)Net income, Q1 FY2025, three months to 2025-03-31−$14.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure(19.5)Net income, Q2 FY2025, three months to 2025-06-30−$19.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure(25.7)Net income, Q3 FY2025, three months to 2025-09-30−$25.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269587.Report this figure(14.0)Net income, Q4 FY2025, three months to 2025-12-31−$14.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001339970-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(10.8)Net income, Q1 FY2026, three months to 2026-03-31−$10.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure(10.3)Net income, Q2 FY2026, three months to 2026-06-30−$10.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure
Diluted EPS$ per share(0.20)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-123305.Report this figurenot reported(0.23)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-07, accession 0000950170-25-065640.Report this figure(0.23)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001339970-25-000009.Report this figure(0.23)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269587.Report this figurenot reported(0.17)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure(0.22)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure(0.26)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269587.Report this figurenot reported(0.11)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure(0.11)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure
Basic EPS$ per share(0.20)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-123305.Report this figurenot reported(0.23)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-07, accession 0000950170-25-065640.Report this figure(0.23)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001339970-25-000009.Report this figure(0.23)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269587.Report this figurenot reported(0.17)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure(0.22)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure(0.26)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-269587.Report this figurenot reported(0.11)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure(0.11)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure

Balance sheet

Cash and equivalents$16.2m, Q2 FY2026
Shareholders' equity$48.8m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m9.8Cash and equivalents, Q3 FY2023, at 2023-09-30$9.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-123305.Report this figure22.5Cash and equivalents, FY2023, at 2023-12-31$22.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-05, accession 0001339970-26-000008.Report this figure6.8Cash and equivalents, Q1 FY2024, at 2024-03-31$6.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-07, accession 0000950170-25-065640.Report this figure6.8Cash and equivalents, Q2 FY2024, at 2024-06-30$6.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001339970-25-000009.Report this figure11.5Cash and equivalents, Q3 FY2024, at 2024-09-30$11.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-269587.Report this figure11.1Cash and equivalents, FY2024, at 2024-12-31$11.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-05, accession 0001339970-26-000008.Report this figure10.4Cash and equivalents, Q1 FY2025, at 2025-03-31$10.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure17.2Cash and equivalents, Q2 FY2025, at 2025-06-30$17.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure6.2Cash and equivalents, Q3 FY2025, at 2025-09-30$6.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-269587.Report this figure10.7Cash and equivalents, FY2025, at 2025-12-31$10.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure10.0Cash and equivalents, Q1 FY2026, at 2026-03-31$10.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure16.2Cash and equivalents, Q2 FY2026, at 2026-06-30$16.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure
Current assets$m107Current assets, Q3 FY2023, at 2023-09-30$107.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062058.Report this figure103Current assets, FY2023, at 2023-12-31$103.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-13, accession 0000950170-25-038888.Report this figure96.9Current assets, Q1 FY2024, at 2024-03-31$96.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-02, accession 0000950170-24-052092.Report this figure90.3Current assets, Q2 FY2024, at 2024-06-30$90.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096185.Report this figure76.3Current assets, Q3 FY2024, at 2024-09-30$76.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123305.Report this figure82.0Current assets, FY2024, at 2024-12-31$82.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-05, accession 0001339970-26-000008.Report this figure83.3Current assets, Q1 FY2025, at 2025-03-31$83.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-065640.Report this figure87.5Current assets, Q2 FY2025, at 2025-06-30$87.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001339970-25-000009.Report this figure93.0Current assets, Q3 FY2025, at 2025-09-30$93.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269587.Report this figure80.2Current assets, FY2025, at 2025-12-31$80.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure67.6Current assets, Q1 FY2026, at 2026-03-31$67.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure58.4Current assets, Q2 FY2026, at 2026-06-30$58.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure
Total assets$m125Total assets, Q3 FY2023, at 2023-09-30$125.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-062058.Report this figure121Total assets, FY2023, at 2023-12-31$120.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-13, accession 0000950170-25-038888.Report this figure113Total assets, Q1 FY2024, at 2024-03-31$113.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-02, accession 0000950170-24-052092.Report this figure106Total assets, Q2 FY2024, at 2024-06-30$105.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0000950170-24-096185.Report this figure91.6Total assets, Q3 FY2024, at 2024-09-30$91.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-123305.Report this figure96.8Total assets, FY2024, at 2024-12-31$96.8m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-05, accession 0001339970-26-000008.Report this figure97.2Total assets, Q1 FY2025, at 2025-03-31$97.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-07, accession 0000950170-25-065640.Report this figure102Total assets, Q2 FY2025, at 2025-06-30$101.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001339970-25-000009.Report this figure107Total assets, Q3 FY2025, at 2025-09-30$106.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-269587.Report this figure93.0Total assets, FY2025, at 2025-12-31$93.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure79.7Total assets, Q1 FY2026, at 2026-03-31$79.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure69.8Total assets, Q2 FY2026, at 2026-06-30$69.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure
Current liabilities$m12.9Current liabilities, Q3 FY2023, at 2023-09-30$12.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062058.Report this figure16.4Current liabilities, FY2023, at 2023-12-31$16.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-13, accession 0000950170-25-038888.Report this figure16.0Current liabilities, Q1 FY2024, at 2024-03-31$16.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-02, accession 0000950170-24-052092.Report this figure11.8Current liabilities, Q2 FY2024, at 2024-06-30$11.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096185.Report this figure14.1Current liabilities, Q3 FY2024, at 2024-09-30$14.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123305.Report this figure15.0Current liabilities, FY2024, at 2024-12-31$15.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-05, accession 0001339970-26-000008.Report this figure10.7Current liabilities, Q1 FY2025, at 2025-03-31$10.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-07, accession 0000950170-25-065640.Report this figure15.5Current liabilities, Q2 FY2025, at 2025-06-30$15.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001339970-25-000009.Report this figure15.7Current liabilities, Q3 FY2025, at 2025-09-30$15.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269587.Report this figure15.1Current liabilities, FY2025, at 2025-12-31$15.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure11.7Current liabilities, Q1 FY2026, at 2026-03-31$11.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure11.4Current liabilities, Q2 FY2026, at 2026-06-30$11.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m98.4Shareholders' equity, Q3 FY2023, at 2023-09-30$98.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-09, accession 0000950170-23-062058.Report this figure90.7Shareholders' equity, FY2023, at 2023-12-31$90.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-13, accession 0000950170-25-038888.Report this figure84.5Shareholders' equity, Q1 FY2024, at 2024-03-31$84.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-02, accession 0000950170-24-052092.Report this figure81.6Shareholders' equity, Q2 FY2024, at 2024-06-30$81.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-13, accession 0000950170-24-096185.Report this figure65.3Shareholders' equity, Q3 FY2024, at 2024-09-30$65.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-123305.Report this figure70.0Shareholders' equity, FY2024, at 2024-12-31$70.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-05, accession 0001339970-26-000008.Report this figure75.1Shareholders' equity, Q1 FY2025, at 2025-03-31$75.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-07, accession 0000950170-25-065640.Report this figure74.8Shareholders' equity, Q2 FY2025, at 2025-06-30$74.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-07, accession 0001339970-25-000009.Report this figure80.2Shareholders' equity, Q3 FY2025, at 2025-09-30$80.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269587.Report this figure67.5Shareholders' equity, FY2025, at 2025-12-31$67.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure57.9Shareholders' equity, Q1 FY2026, at 2026-03-31$57.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure48.8Shareholders' equity, Q2 FY2026, at 2026-06-30$48.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure

Cash flow

Operating cash flow−$9.4m, Q2 FY2026
Capital expenditure$73.0k, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(9.6)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$9.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-123305. Derived: 9-month figure less the 6-month figure.Report this figure(11.1)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$11.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001339970-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(22.4)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$22.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-07, accession 0000950170-25-065640.Report this figure(20.4)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$20.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001339970-25-000009. Derived: 6-month figure less the 3-month figure.Report this figure(13.2)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$13.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269587. Derived: 9-month figure less the 6-month figure.Report this figure(13.1)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$13.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001339970-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(15.4)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$15.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure(13.9)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$13.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001339970-26-000053. Derived: 6-month figure less the 3-month figure.Report this figure(20.5)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$20.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269587. Derived: 9-month figure less the 6-month figure.Report this figure(12.2)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$12.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001339970-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(12.5)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$12.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure(9.4)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$9.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001339970-26-000053. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.6Capital expenditure, Q3 FY2023, three months to 2023-09-30$557.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-123305. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$17.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001339970-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$17.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-07, accession 0000950170-25-065640.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$8.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001339970-25-000009. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$15.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269587. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$25.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001339970-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$9.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001339970-26-000053. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$37.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269587. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$31.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001339970-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$138.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$73.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001339970-26-000053. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)98.07m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares28.7Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3028,663,047 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-062058.Report this figure41.9Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3141,897,706 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-02, accession 0000950170-24-052092.Report this figure55.1Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3055,143,805 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0000950170-24-096185.Report this figure57.9Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3057,885,393 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-123305.Report this figure66.1Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3166,080,593 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-07, accession 0000950170-25-065640.Report this figure72.3Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3072,284,351 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001339970-25-000009.Report this figure75.8Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3075,801,666 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269587.Report this figure86.5Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3186,485,126 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure90.1Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3090,120,235 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure97.2Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3097,153,541 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-269587.Report this figure98.0Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3198,043,839 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001339970-26-000033.Report this figure98.1Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3098,069,915 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure

Shares outstanding: 98.09mShares outstanding, period not labelled, at 2026-07-3198,087,425 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-07, accession 0001339970-26-000053.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 7, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. Listed shows no prices and gives no investment advice.